Obesity and prostate cancer: epidemiology and clinical implications.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European Urology

• Publication date

  2007-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.EURURO.2007.04.069PMID 17507151
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostate cancer.

  2019cited by this paper
• Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.

  2007cited by this paper
• Effects of soy phytoestrogens on the prostate

  2007cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• Development and external validation of an extended 10-core biopsy nomogram.

  2007cited by this paper
• Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.

  2007cited by this paper
• Relationship between body mass index and prostate cancer screening in the United States.

  2007cited by this paper
• Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle‐aged men

  2007influential reference
• Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality

  2007cited by this paper
• 1418: Can Hemodilution Explain the Lower PSA Concentrations Among Obese Men?

  2007cited by this paper
• A single-institution comparison between radical perineal and radical retropubic prostatectomy on perioperative and pathological outcomes for obese men: an analysis of the Duke Prostate Center database.

  2007cited by this paper
• Prevalence of overweight and obesity in rural and urban settings of 10 European countries.

  2007cited by this paper
• Obesity Is Negatively Associated with Prostate-Specific Antigen in U.S. Men, 2001-2004

  2007cited by this paper
• Prostate volume modifies the association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasia

  2007cited by this paper
• Body Mass Index, Weight Change, and Risk of Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort

  2007influential reference
• Circulating Steroid Hormones and the Risk of Prostate Cancer

  2006cited by this paper
• Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection.

  2006cited by this paper
• Influence of obesity on biochemical and clinical failure after external‐beam radiotherapy for localized prostate cancer

  2006cited by this paper
• The link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives

  2006cited by this paper
• Adipose tissue-derived factors: impact on health and disease.

  2006cited by this paper
• Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality.

  2006cited by this paper
• Is there a role for a low-carbohydrate ketogenic diet in the management of prostate cancer?

  2006cited by this paper
• Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy.

  2006cited by this paper
• The metabolic syndrome is associated with reduced risk of prostate cancer.

  2006cited by this paper
• Diet After Diagnosis and the Risk of Prostate Cancer Progression, Recurrence, and Death (United States)

  2006cited by this paper
• Body size and composition and prostate cancer risk: systematic review and meta-regression analysis

  2006cited by this paper
• Dietary Patterns and Risk of Prostate Cancer in U.S. Men

  2006cited by this paper
• Obesity, Adipokines, and Prostate Cancer in a Prospective Population-Based Study

  2006cited by this paper
• Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years.

  2006cited by this paper
• Molecular Interactions of Leptin and Prostate Cancer

  2006cited by this paper
• Obesity and survival after radical prostatectomy: A 10‐year prospective cohort study

  2006cited by this paper
• Obesity, adipokines, and prostate cancer (review).

  2006cited by this paper
• Testosterone and prostate cancer: an historical perspective on a modern myth.

  2006cited by this paper
• Obesity adversely affects health related quality of life before and after radical retropubic prostatectomy.

  2006cited by this paper
• Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial.

  2006cited by this paper
• Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

  2006influential reference
• Meat Consumption among Black and White Men and Risk of Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort

  2006cited by this paper
• The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE).

  2005cited by this paper
• Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.

  2005cited by this paper
• Obesity does not adversely affect health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy.

  2005cited by this paper
• Role of diet in prostate cancer development and progression.

  2005cited by this paper
• Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy

  2005cited by this paper
• The association of body mass index and prostate‐specific antigen in a population‐based study

  2005cited by this paper
• Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program.

  2005cited by this paper
• Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomy.

  2005cited by this paper
• Sex Steroid Hormones and the Androgen Receptor Gene CAG Repeat and Subsequent Risk of Prostate Cancer in the Prostate-Specific Antigen Era

  2005cited by this paper
• Prostate cancer and adiponectin.

  2005cited by this paper
• Influence of body mass index on biochemical outcome after permanent prostate brachytherapy.

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• A prospective study of meat and meat mutagens and prostate cancer risk.

  2005cited by this paper
• Body mass index as a predictor of prostate cancer: development versus detection on biopsy.

  2005influential reference
• Macronutrients, fatty acids, cholesterol and prostate cancer risk.

  2005cited by this paper
• Obesity before age 30 years and risk of advanced prostate cancer.

  2005cited by this paper
• The association of body mass index and prostate-specific antigen in a population-based study.

  2005cited by this paper
• Serum leptin and pathological findings at the time of radical prostatectomy.

  2005cited by this paper
• Obesity and capsular incision at the time of open retropubic radical prostatectomy.

  2005cited by this paper
• International Trends in Prostate-Cancer Mortality: The Decrease is Continuing and Spreading

  2004cited by this paper
• Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population.

  2004cited by this paper
• Overexpressing leptin genetic polymorphism (−2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease

  2004cited by this paper
• Pathophysiology of insulin secretion.

  2004cited by this paper
• Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging.

  2004cited by this paper
• Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

  2004cited by this paper
• Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study.

  2004cited by this paper
• Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis.

  2004cited by this paper
• Glycemic index, glycemic load and risk of prostate cancer

  2004cited by this paper
• Demographic and clinical factors as determinants of serum levels of prostate specific antigen and its derivatives.

  2004cited by this paper
• Prostate cancer and body size at different ages: an Italian multicentre case–control study

  2004cited by this paper
• Prevention of prostate cancer by androgens: experimental paradox or clinical reality.

  2004cited by this paper
• Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

  2004influential reference
• Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group.

  2004influential reference
• Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer.

  2004cited by this paper
• Diabetes mellitus and risk of prostate cancer: a meta-analysis

  2004cited by this paper
• Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets.

  2004cited by this paper
• Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins.

  2004cited by this paper
• Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy.

  2004influential reference
• Prostate Cancer Cell-Adipocyte Interaction LEPTIN MEDIATES ANDROGEN-INDEPENDENT PROSTATE CANCER CELL PROLIFERATION THROUGH c-Jun NH 2 -TERMINAL KINASE*

  2003cited by this paper
• Plasma leptin is not associated with prostate cancer risk.

  2003cited by this paper
• Prostate Cancer Cell-Adipocyte Interaction

  2003cited by this paper
• Nutrition, Insulin, Insulin-like Growth Factors and Cancer

  2003cited by this paper
• Polymorphism of the insulin gene is associated with increased prostate cancer risk

  2003cited by this paper
• Height, body mass index, and prostate cancer: a follow-up of 950 000 Norwegian men

  2003cited by this paper
• Leptin influences cellular differentiation and progression in prostate cancer.

  2003cited by this paper
• Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

  2003cited by this paper
• Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men.

  2003cited by this paper
• Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy.

  2003cited by this paper
• Body mass index and risk of prostate cancer in U.S. health professionals.

  2003cited by this paper
• Insulin resistance and prostate cancer risk.

  2003cited by this paper
• Association of energy intake with prostate cancer in a long-term aging study: Baltimore Longitudinal Study of Aging (United States).

  2003cited by this paper
• Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations.

  2002cited by this paper
• Body mass index in young adulthood and cancer mortality: a retrospective cohort study

  2002cited by this paper
• Energy from fat is associated with obesity in U.S. men: results from the Prostate Cancer Prevention Trial.

  2002cited by this paper
• Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia.

  2002cited by this paper
• Energy imbalance and prostate cancer.

  2002cited by this paper
• Prevalence and trends in obesity among US adults, 1999-2000.

  2002cited by this paper
• Insulin-like Growth Factors

  2002cited by this paper
• Associations of energy, fat, calcium, and vitamin D with prostate cancer risk.

  2002cited by this paper
• Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States.

  2001influential reference
• High‐grade prostate cancer is associated with low serum testosterone levels

  2001cited by this paper
• Leptin and prostate cancer

  2001cited by this paper
• Prostate cancer risk and serum levels of insulin and leptin: a population-based study.

  2001cited by this paper

• DNA Repair Capacity and Clinicopathological Characteristics in Puerto Rican Hispanic/Latino Patients with Metastatic Castration-Resistant Prostate Cancer

  2025cites this paper
• Platycodi Radix Extract Prevents Hepatic Steatosis by Enhancing Bile Acid Synthesis in a High-Fat Diet-Induced Fatty Liver Mouse Model

  2024cites this paper
• Defining the genetic profile of prostate cancer.

  2024cites this paper
• Nutrition, GH/IGF-I signaling, and cancer.

  2024cites this paper
• SDoH-Aware Approach to Prostate Cancer Screening: Addressing Overdiagnosis of Prostate Cancer using PSA

  2024cites this paper
• Predicted body fat percentage, fat mass and lean body mass in relation to risk of prostate cancer: Results from the NHANES 1999 to 2010

  2024cites this paper
• Unraveling molecular interconnections and identifying potential therapeutic targets of significance in obesity-cancer link

  2024cites this paper
• The association between diabetes mellitus and prostate cancer: a meta-analysis and Mendelian randomization

  2024cites this paper
• Obesity and risk of prostate cancer

  2023cites this paper
• Resistin stimulates PC-3 prostate cancer cell growth through stimulation of SOCS3 and SOCS5 genes

  2023cites this paper
• The Role of Isoflavones in the Prevention of Breast Cancer and Prostate Cancer

  2023cites this paper
• Decoding the Influence of Obesity on Prostate Cancer and Its Transgenerational Impact

  2023cites this paper
• Investigating the association between Veteran status and rate of emergency department visits

  2023cites this paper
• CÁNCER DE PRÓSTATA ASOCIADO A SÍNDROME METABÓLICO

  2023cites this paper
• GI factors, potential to predict prostate motion during radiotherapy; a scoping review

  2023cites this paper
• Association between obesity and frequency of high-grade prostate cancer on biopsy in men: A single-center retrospective study

  2022cites this paper
• FABP4 in obesity-associated carcinogenesis: Novel insights into mechanisms and therapeutic implications

  2022cites this paper
• Protective effect of indole-3-carbinol on testis of a high fat diet induced obesity

  2022cites this paper
• Leptin modulated microRNA-628-5p targets Jagged-1 and inhibits prostate cancer hallmarks

  2022cites this paper
• Novel insights into the consequences of obesity: a phenotype-wide Mendelian randomization study

  2022cites this paper
• The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer

  2022cites this paper
• Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer

  2022cites this paper
• Aberrant Expression of COX-2 and FOXG1 in Infrapatellar Fat Pad-Derived ASCs from Pre-Diabetic Donors

  2022cites this paper
• Interplay between Prostate Cancer and Adipose Microenvironment: A Complex and Flexible Scenario

  2022cites this paper
• Exploring Health Outcomes for U.S. Veterans Compared to Non-Veterans from 2003 to 2019

  2021cites this paper
• Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer

  2021cites this paper
• Obesity and prostate cancer: a narrative review.

  2021cites this paper
• Association of metabolic syndrome with prostate cancer diagnosis and aggressiveness in patients undergoing transrectal prostate biopsy.

  2021cites this paper
• Tissue cholesterol metabolism and prostate cancer aggressiveness: Ethno‐geographic variations

  2021cites this paper
• The Association Of Body Mass Index And Prostatic Cancer Histopathological Grade

  2021cites this paper
• Psychological intervention to treat distress: An emerging frontier in cancer prevention and therapy.

  2021cites this paper
• Prostate cancer: Therapeutic prospect with herbal medicine

  2021cites this paper
• An Amplified Fatty Acid-Binding Protein Gene Cluster in Prostate Cancer: Emerging Roles in Lipid Metabolism and Metastasis

  2020cites this paper
• Assessment of levels of Vitamin D and Leptin in comparison of BMI among medical students

  2020cites this paper
• Metabolically Abnormal Obesity Increases the Risk of Advanced Prostate Cancer in Chinese Patients Undergoing Radical Prostatectomy

  2020cites this paper
• Dr. Answer AI Software for Prostate Cancer: Explainable Variable Importance of Predicting T Stage

  2020cites this paper
• Thickness of Perirenal Fat Predicts the Growth Pattern of Renal Cell Carcinoma

  2020cites this paper
• Mucosa grafts urethroplasty in hypospadias-associated urethral stricture: critical factors for treatment selection

  2020cites this paper
• The Role of Metabolic Factors in Renal Cancers

  2020cites this paper
• Efficacy of a weight loss program prior to robot assisted radical prostatectomy in overweight and obese men with prostate cancer.

  2020cites this paper
• The FABP12/PPARγ pathway promotes metastatic transformation by inducing epithelial‐to‐mesenchymal transition and lipid‐derived energy production in prostate cancer cells

  2020cites this paper
• The FABP12/PPARc pathway promotes metastatic transformation by inducing epithelial-to-mesenchymal transition and lipid-derived energy production in prostate cancer cells

  2020cites this paper
• Obesity and Prostate Cancer: The Tip of a High Mountain Still to Be Conquered

  2020cites this paper
• Morbid Obesity and Frailty

  2020cites this paper
• CMAR_A_242193 1779..1787

  2020cites this paper
• Allopurinol and the risk of prostate cancer in a Finnish population-based cohort

  2019cites this paper
• Androgen deprivation therapy promotes an obesity-like microenvironment in periprostatic fat

  2019cites this paper
• The Polyphenols as Potential Agents in Prevention and Therapy of Prostate Diseases

  2019cites this paper
• Appetite-regulating hormones—leptin, adiponectin and ghrelin—and the development of prostate cancer: a systematic review and exploratory meta-analysis

  2019cites this paper
• Effect of glucose and palmitate environment on proliferation and migration of PC3‐prostate cancer cells

  2019cites this paper
• Coping with chemoresistance in prostate cancer-co-targeting of adipose stromal cells?

  2019cites this paper
• Prostate cancer in young men: An emerging young adult and older adolescent challenge

  2019cites this paper
• Body fat distribution on computed tomography imaging and prostate cancer risk and mortality in the AGES‐Reykjavik study

  2019cites this paper
• Thick perirenal fat predicts the growth pattern of renal cell carcinoma

  2019cites this paper
• Latest Evidence on the Impact of Smoking, Sports, and Sexual Activity as Modifiable Lifestyle Risk Factors for Prostate Cancer Incidence, Recurrence, and Progression: A Systematic Review of the Literature by the European Association of Urology Section of Oncological Urology (ESOU).

  2019cites this paper
• 3,3′-Diindolylmethane Dose-Dependently Prevents Advanced Prostate Cancer

  2019cites this paper
• A study on molecular mechanisms of adiposis induced by long-term treatment of high-fat and high-sucrose in C57BL/6J mice.

  2019cites this paper
• Impact of Obesity and Expression of Obesity-Related Genes in the Progression of Prostate Cancer in African American Men

  2018cites this paper
• Clinical association of metabolic syndrome, C‐reactive protein and testosterone levels with clinically significant prostate cancer

  2018cites this paper
• Impact of metabolic syndrome on oncologic outcomes at radical prostatectomy.

  2018cites this paper
• Obesity suppresses tumor attributable PSA, affecting risk categorization.

  2018cites this paper
• Adipose tissue:Critical contributor to the development of prostate cancer.

  2018cites this paper
• Yüksek Yağlı Diyetle Beslenen Sıçanlarda Gundelia tournefortii L. Bitki Ekstresinin Hematolojik Parametreler Üzerine Etkisi

  2018cites this paper
• Prostate Cancer Metabolism in the Interplay of Obesity and Estrogens Actions

  2018cites this paper
• Riesgo litiásico y deprivación androgénica en pacientes con cáncer de próstata avanzado

  2018cites this paper
• The Role of Adiponectin in Prostate Cancer: A Narrative Review

  2017cites this paper
• THE ROLE OF OBESITY IN ALTERATION OF PROSTAT SPECIFIC ANTIGEN AND ACID PHOSPHATASE IN ADULT YOUNG SUDANESE MALES

  2017cites this paper
• Profile of users treated in oncology reference services in Montes Claros – MG.

  2017cites this paper
• Leptin in Cancer: Epidemiology and Mechanisms

  2017cites this paper
• Prostate Cancer Detected by Screening in a Semi Urban Community in Southeast Nigeria: Correlations and Associations between Anthropometric Measurements and Prostate-specific Antigen

  2017cites this paper
• The emerging role of obesity, diet and lipid metabolism in prostate cancer.

  2017cites this paper
• The “ins and outs” of prostate metabolism towards carcinogenesis: the case of methoxychlor

  2017cites this paper
• Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer

  2017cites this paper
• Body mass index as a classifier to predict biochemical recurrence after radical prostatectomy in patients with lower prostate-specific antigen levels.

  2017cites this paper
• Association of Family History of Type 2 Diabetes with Prostate Cancer: A National Cohort Study

  2016cites this paper
• The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer

  2016cites this paper
• The Relationship between Obesity, Prostate Tumor Infiltrating Lymphocytes and Macrophages, and Biochemical Failure

  2016cites this paper
• Uric acid: a modulator of prostate cells and activin sensitivity

  2016cites this paper
• Adult weight gain and risk of prostate cancer: A dose–response meta‐analysis of observational studies

  2016cites this paper
• Glucose Metabolism in High-Risk Prostate Cancer Patients throughout the Acute Disease Trajectory

  2016cites this paper
• WITHDRAWN: Current opinion in the role of testosterone in the development of prostate cancer: A dynamic model

  2016cites this paper
• Prostate Cancer Among Asian Americans

  2016cites this paper
• Etiology of prostate cancer ( C 61 ) in Central and South America

  2016cites this paper
• The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate Cancer

  2016cites this paper
• Deaths: Obesity – Pathology

  2016cites this paper
• Complex relationship between sex hormones, insulin resistance and leptin in men with and without prostatic disease

  2016cites this paper
• Prevalence of Hypogonadism in Low-Risk Prostate Cancer Survivors.

  2016cites this paper
• Periprostatic Fat: A Risk Factor for Prostate Cancer?

  2016cites this paper
• Prostate cancer burden in Central and South America.

  2016cites this paper
• A review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patients

  2016cites this paper
• Prostate cancer patients may have an increased risk of coexisting advanced colorectal neoplasms

  2016cites this paper
• Leptin contributes to long-term stabilization of HIF-1α in cancer cells subjected to oxygen limiting conditions.

  2016cites this paper
• The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium

  2015cites this paper
• Obesity and Cancer Progression: Is There a Role of Fatty Acid Metabolism?

  2015cites this paper
• Current opinion on the role of testosterone in the development of prostate cancer: a dynamic model

  2015cites this paper
• Adiponectin inhibits VEGF-A in prostate cancer cells

  2015influential citation
• Effects of thymoquinone on testicular structure and sperm production in male obese rats

  2015influential citation
• Concurrent Diabetes Mellitus may Negatively Influence Clinical Progression and Response to Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer

  2015cites this paper
• Individual- and neighborhood-level education influences the effect of obesity on prostate cancer treatment failure after prostatectomy

  2015cites this paper
• Concise Review: The Obesity Cancer Paradigm: Exploration of the Interactions and Crosstalk with Adipose Stem Cells

  2015cites this paper